Axsome Therapeutics AXSM

$ 98.86 -8.37%

Annual report 2024
added 02-18-2025

Axsome Therapeutics EV/EBITDA Ratio 2011-2025 | AXSM

Annual EV/EBITDA Ratio Axsome Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-8.03	-24.3	-41.9	-6.66	-1.47	-2.33	-6.58	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-1.47	-41.9	-13